HIV-1 envelope glycoprotein structure

Current Opinion in Structural Biology

Volumn 23, Issue 2, 2013, Pages 268-276

  Merk, Alan ^a   Subramaniam, Sriram ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41;

COMPLEX FORMATION; COMPUTER MODEL; CONFORMATIONAL TRANSITION; CRYOELECTRON MICROSCOPY; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG RESEARCH; ELECTRON TOMOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; VIRUS CELL INTERACTION; VIRUS ENTRY; X RAY CRYSTALLOGRAPHY;

CRYOELECTRON MICROSCOPY; CRYSTALLOGRAPHY, X-RAY; ELECTRON MICROSCOPE TOMOGRAPHY; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HUMANS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84878618663     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2013.03.007     Document Type: Review

References (82)

1. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85:1135-1148.
2. McDougal J.S., Kennedy M.S., Sligh J.M., Cort S.P., Mawle A., Nicholson J.K. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science 1986, 231:382-385.
3. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877.
4. Maddon P.J., Dalgleish A.G., McDougal J.S., Clapham P.R., Weiss R.A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986, 47:333-348.
5. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958.
6. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
7. Doranz B.J., Rucker J., Yi Y., Smyth R.J., Samson M., Peiper S.C., Parmentier M., Collman R.G., Doms R.W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996, 85:1149-1158.
8. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
9. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393:648-659.
10. Madani N., Schon A., Princiotto A.M., Lalonde J.M., Courter J.R., Soeta T., Ng D., Wang L., Brower E.T., Xiang S.H., et al. Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120. Structure 2008, 16:1689-1701.
11. LaLonde J.M., Kwon Y.D., Jones D.M., Sun A.W., Courter J.R., Soeta T., Kobayashi T., Princiotto A.M., Wu X., Schon A., et al. Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors. J Med Chem 2012, 55:4382-4396.
12. Wu X., Yang Z.Y., Li Y., Hogerkorp C.M., Schief W.R., Seaman M.S., Zhou T., Schmidt S.D., Wu L., Xu L., et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 2010, 329:856-861.
13. Kwong P.D., Wyatt R., Majeed S., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Structure 2000, 8:1329-1339.
14. Huang C.C., Tang M., Zhang M.Y., Majeed S., Montabana E., Stanfield R.L., Dimitrov D.S., Korber B., Sodroski J., Wilson I.A., et al. Structure of a V3-containing HIV-1 gp120 core. Science 2005, 310:1025-1028.
15. Huang C.C., Lam S.N., Acharya P., Tang M., Xiang S.H., Hussan S.S., Stanfield R.L., Robinson J., Sodroski J., Wilson I.A., et al. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 2007, 317:1930-1934.
16. Zhou T., Xu L., Dey B., Hessell A.J., Van Ryk D., Xiang S.H., Yang X., Zhang M.Y., Zwick M.B., Arthos J., et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 2007, 445:732-737.
17. Pancera M., Majeed S., Ban Y.E., Chen L., Huang C.C., Kong L., Kwon Y.D., Stuckey J., Zhou T., Robinson J.E., et al. Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility. Proc Natl Acad Sci U S A 2010, 107:1166-1171.
18. Chen L., Kwon Y.D., Zhou T., Wu X., O'Dell S., Cavacini L., Hessell A.J., Pancera M., Tang M., Xu L., et al. Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120. Science 2009, 326:1123-1127.
19. Diskin R., Marcovecchio P.M., Bjorkman P.J. Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity. Nat Struct Mol Biol 2010, 17:608-613.
20. Zhou T., Georgiev I., Wu X., Yang Z.Y., Dai K., Finzi A., Kwon Y.D., Scheid J.F., Shi W., Xu L., et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 2010, 329:811-817.
21. Wu X., Zhou T., Zhu J., Zhang B., Georgiev I., Wang C., Chen X., Longo N.S., Louder M., McKee K., et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 2011, 333:1593-1602.
22. Pejchal R., Doores K.J., Walker L.M., Khayat R., Huang P.S., Wang S.K., Stanfield R.L., Julien J.P., Ramos A., Crispin M., et al. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 2011.
23. Diskin R., Scheid J.F., Marcovecchio P.M., West A.P., Klein F., Gao H., Gnanapragasam P.N., Abadir A., Seaman M.S., Nussenzweig M.C., et al. Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science 2011, 334:1289-1293.
24. Kwon Y.D., Finzi A., Wu X., Dogo-Isonagie C., Lee L.K., Moore L.R., Schmidt S.D., Stuckey J., Yang Y., Zhou T., et al. Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proc Natl Acad Sci U S A 2012, 109:5663-5668.
25. Guttman M., Kahn M., Garcia N.K., Hu S.L., Lee K.K. Solution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120. J Virol 2012, 86:8750-8764.
26. McLellan J.S., Pancera M., Carrico C., Gorman J., Julien J.P., Khayat R., Louder R., Pejchal R., Sastry M., Dai K., et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 2011, 480:336-343.
27. Liao H.X., Bonsignori M., Alam S.M., McLellan J.S., Tomaras G.D., Moody M.A., Kozink D.M., Hwang K.K., Chen X., Tsao C.Y., et al. Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity 2013.
28. Stanfield R., Cabezas E., Satterthwait A., Stura E., Profy A., Wilson I. Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs. Structure 1999, 7:131-142.
29. Chen B., Vogan E.M., Gong H., Skehel J.J., Wiley D.C., Harrison S.C. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005, 433:834-841.
30. Milne J.L., Subramaniam S. Cryo-electron tomography of bacteria: progress, challenges and future prospects. Nat Rev Microbiol 2009, 7:666-675.
31. Meyerson J.R., White T.A., Bliss D., Moran A., Bartesaghi A., Borgnia M.J., de la Cruz M.J., Schauder D., Hartnell L.M., Nandwani R., et al. Determination of molecular structures of HIV envelope glycoproteins using cryo-electron tomography and automated sub-tomogram averaging. J Vis Exp 2011.
32. Milne J.L., Borgnia M.J., Bartesaghi A., Tran E.E., Earl L.A., Schauder D.M., Lengyel J., Pierson J., Patwardhan A., Subramaniam S. Cryo-electron microscopy - a primer for the non-microscopist. FEBS J 2013, 280:28-45.
33. Meyerson J.R., Tran E.E., Kuybeda O., Chen W., Dimitrov D.S., Gorlani A., Verrips T., Lifson J.D., Subramaniam S. Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives. Proc Natl Acad Sci U S A 2013, 110:513-518.
34. Harris A., Borgnia M.J., Shi D., Bartesaghi A., He H., Pejchal R., Kang Y.K., Depetris R., Marozsan A.J., Sanders R.W., et al. Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci U S A 2011, 108:11440-11445.
35. Bartesaghi A., Sprechmann P., Liu J., Randall G., Sapiro G., Subramaniam S. Classification and 3D averaging with missing wedge correction in biological electron tomography. J Struct Biol 2008, 162:436-450.
36. Tran E.E., Borgnia M.J., Kuybeda O., Schauder D.M., Bartesaghi A., Frank G.A., Sapiro G., Milne J.L., Subramaniam S. Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog 2012, 8:e1002797.
37. White T.A., Bartesaghi A., Borgnia M.J., de la Cruz M.J., Nandwani R., Hoxie J.A., Bess J.W., Lifson J.D., Milne J.L., Subramaniam S. 3D structures of sCD4-bound states of trimeric SIV envelope glycoproteins determined using cryo-electron tomography. J Virol 2011.
38. White T.A., Bartesaghi A., Borgnia M.J., Meyerson J.R., de la Cruz M.J., Bess J.W., Nandwani R., Hoxie J.A., Lifson J.D., Milne J.L., et al. Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog 2010, 6:e1001249.
39. Moscoso C.G., Sun Y., Poon S., Xing L., Kan E., Martin L., Green D., Lin F., Vahlne A.G., Barnett S., et al. Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand binding. Proc Natl Acad Sci U S A 2011, 108:6091-6096.
40. Hu G., Liu J., Taylor K.A., Roux K.H. Structural comparison of HIV-1 envelope spikes with and without the V1/V2 loop. J Virol 2011, 85:2741-2750.
41. LaBranche C.C., Hoffman T.L., Romano J., Haggarty B.S., Edwards T.G., Matthews T.J., Doms R.W., Hoxie J.A. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity. J Virol 1999, 73:10310-10319.
42. Dumonceaux J., Nisole S., Chanel C., Quivet L., Amara A., Baleux F., Briand P., Hazan U. Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J Virol 1998, 72:512-519.
43. Li Y., O'Dell S., Walker L.M., Wu X., Guenaga J., Feng Y., Schmidt S.D., McKee K., Louder M.K., Ledgerwood J.E., et al. Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. J Virol 2011, 85:8954-8967.
44. Chan D.C., Fass D., Berger J.M., Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997, 89:263-273.
45. Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 1997, 387:426-430.
46. Tan K., Liu J., Wang J., Shen S., Lu M. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A 1997, 94:12303-12308.
47. Wild C., Greenwell T., Matthews T. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res Hum Retroviruses 1993, 9:1051-1053.
48. Wild C.T., Shugars D.C., Greenwell T.K., McDanal C.B., Matthews T.J. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci U S A 1994, 91:9770-9774.
49. He Y., Xiao Y., Song H., Liang Q., Ju D., Chen X., Lu H., Jing W., Jiang S., Zhang L. Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor. J Biol Chem 2008, 283:11126-11134.
50. Chong H., Yao X., Sun J., Qiu Z., Zhang M., Waltersperger S., Wang M., Cui S., He Y. The M-T hook structure is critical for design of HIV-1 fusion inhibitors. J Biol Chem 2012, 287:34558-34568.
51. Ouyang W., An T., Guo D., Wu S., Tien P The potent Human Immunodeficiency Virus Type 1 (HIV-1) entry inhibitor HR212 blocks formation of the envelope glycoprotein gp41 six-helix bundle. AIDS Res Hum Retroviruses 2013.
52. Caffrey M., Cai M., Kaufman J., Stahl S.J., Wingfield P.T., Covell D.G., Gronenborn A.M., Clore G.M. Three-dimensional solution structure of the 44kDa ectodomain of SIV gp41. EMBO J 1998, 17:4572-4584.
53. Shu W., Ji H., Lu M. Interactions between HIV-1 gp41 core and detergents and their implications for membrane fusion. J Biol Chem 2000, 275:1839-1845.
54. Frey G., Chen J., Rits-Volloch S., Freeman M.M., Zolla-Pazner S., Chen B. Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies. Nat Struct Mol Biol 2010, 17:1486-1491.
55. Gustchina E., Li M., Louis J.M., Anderson D.E., Lloyd J., Frisch C., Bewley C.A., Gustchina A., Wlodawer A., Clore G.M. Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41. PLoS Pathog 2010, 6:e1001182.
56. Luftig M.A., Mattu M., Di Giovine P., Geleziunas R., Hrin R., Barbato G., Bianchi E., Miller M.D., Pessi A., Carfi A. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody. Nat Struct Mol Biol 2006, 13:740-747.
57. Sabin C., Corti D., Buzon V., Seaman M.S., Lutje Hulsik D., Hinz A., Vanzetta F., Agatic G., Silacci C., Mainetti L., et al. Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41. PLoS Pathog 2010, 6:e1001195.
58. Bai X., Wilson K.L., Seedorff J.E., Ahrens D., Green J., Davison D.K., Jin L., Stanfield-Oakley S.A., Mosier S.M., Melby T.E., et al. Impact of the enfuvirtide resistance mutation N43D and the associated baseline polymorphism E137K on peptide sensitivity and six-helix bundle structure. Biochemistry 2008, 47:6662-6670.
59. Izumi K., Nakamura S., Nakano H., Shimura K., Sakagami Y., Oishi S., Uchiyama S., Ohkubo T., Kobayashi Y., Fujii N., et al. Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41 amino-terminal heptad repeat. Antiviral Res 2010, 87:179-186.
60. Ji H., Shu W., Burling F.T., Jiang S., Lu M. Inhibition of human immunodeficiency virus type 1 infectivity by the gp41 core: role of a conserved hydrophobic cavity in membrane fusion. J Virol 1999, 73:8578-8586.
61. Liu J., Shu W., Fagan M.B., Nunberg J.H., Lu M. Structural and functional analysis of the HIV gp41 core containing an Ile573 to Thr substitution: implications for membrane fusion. Biochemistry 2001, 40:2797-2807.
62. Lu M., Stoller M.O., Wang S., Liu J., Fagan M.B., Nunberg J.H. Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis. J Virol 2001, 75:11146-11156.
63. Shu W., Liu J., Ji H., Radigen L., Jiang S., Lu M. Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides. Biochemistry 2000, 39:1634-1642.
64. Wang S., York J., Shu W., Stoller M.O., Nunberg J.H., Lu M. Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion. Biochemistry 2002, 41:7283-7292.
65. Lee J.E., Fusco M.L., Hessell A.J., Oswald W.B., Burton D.R., Saphire E.O. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008, 454:177-182.
66. Ofek G., Tang M., Sambor A., Katinger H., Mascola J.R., Wyatt R., Kwong P.D. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol 2004, 78:10724-10737.
67. Cardoso R.M., Zwick M.B., Stanfield R.L., Kunert R., Binley J.M., Katinger H., Burton D.R., Wilson I.A. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 2005, 22:163-173.
68. Pejchal R., Gach J.S., Brunel F.M., Cardoso R.M., Stanfield R.L., Dawson P.E., Burton D.R., Zwick M.B., Wilson I.A. A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies. J Virol 2009, 83:8451-8462.
69. Huang J., Ofek G., Laub L., Louder M.K., Doria-Rose N.A., Longo N.S., Imamichi H., Bailer R.T., Chakrabarti B., Sharma S.K., et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 2012, 491:406-412.
70. Corti D., Voss J., Gamblin S.J., Codoni G., Macagno A., Jarrossay D., Vachieri S.G., Pinna D., Minola A., Vanzetta F., et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011, 333:850-856.
71. Dreyfus C., Laursen N.S., Kwaks T., Zuijdgeest D., Khayat R., Ekiert D.C., Lee J.H., Metlagel Z., Bujny M.V., Jongeneelen M., et al. Highly conserved protective epitopes on influenza B viruses. Science 2012, 337:1343-1348.
72. Ekiert D.C., Bhabha G., Elsliger M.A., Friesen R.H., Jongeneelen M., Throsby M., Goudsmit J., Wilson I.A. Antibody recognition of a highly conserved influenza virus epitope. Science 2009, 324:246-251.
73. Ekiert D.C., Friesen R.H., Bhabha G., Kwaks T., Jongeneelen M., Yu W., Ophorst C., Cox F., Korse H.J., Brandenburg B., et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011, 333:843-850.
74. Harris A.K., Meyerson J.R., Matsuoka Y., Kuybeda O., Moran A., Bliss D., Das S.R., Yewdell J.W., Sapiro G., Subbarao K., et al. Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies. Proc Natl Acad Sci U S A 2013.
75. Alam S.M., Morelli M., Dennison S.M., Liao H.X., Zhang R., Xia S.M., Rits-Volloch S., Sun L., Harrison S.C., Haynes B.F., et al. Role of HIV membrane in neutralization by two broadly neutralizing antibodies. Proc Natl Acad Sci U S A 2009, 106:20234-20239.
76. Blumenthal R., Durell S., Viard M. HIV entry and envelope glycoprotein-mediated fusion. J Biol Chem 2012, 287:40841-40849.
77. Klasse P.J. The molecular basis of HIV entry. Cell Microbiol 2012, 14:1183-1192.
78. Wilen C.B., Tilton J.C., Doms R.W. HIV: cell binding and entry. Cold Spring Harb Perspect Med 2012, 2.
79. Harris, AK, Bartesaghi, A, Milne, JLS, Subramaniam, S, HIV-1 envelope glycoprotein trimers display open quaternary conformation when bound to the gp41 MPER-directed broadly neutralizing antibody Z13e1. J. Virology 2013, (in press).
80. Frank G.A., Bartesaghi A., Kuybeda O., Borgnia M.J., White T.A., Sapiro G., Subramaniam S. Computational separation of conformational heterogeneity using cryo-electron tomography and 3D sub-volume averaging. J Struct Biol 2012, 178:165-176.
81. Kuybeda O., Frank G.A., Bartesaghi A., Borgnia M., Subramaniam S., Sapiro G. A collaborative framework for 3D alignment and classification of heterogeneous subvolumes in cryo-electron tomography. J Struct Biol 2013, 181:116-127.
82. Bartesaghi A., Lecumberry F., Sapiro G., Subramaniam S. Protein secondary structure determination by constrained single-particle cryo-electron tomography. Structure 2012, 20:2003-2013.